20
Teva Pharmaceutical Industries Ltd, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ENZALUTAMIDE, with a corresponding US DMF Number 29872.
Remarkably, this DMF maintains an Active status since its submission on May 24, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 06, 2016, and payment made on May 13, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II